| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Koo Richard | Director | Sell | 47,782 | $18.18 | $868,891.78 | -16.2% | |
| May 27, 2020 | DVAX Dynavax Technologies Corp | Hack Andrew A. F.62 | Director | Buy | 1,000,000 | $5.00 | $5,000,000.00 | +13.3% | |
| May 26, 2020 | EBS Emergent Biosolutions Inc. | Zoon Kathryn C62 | Director | Sell | 4,093 | $85.10 | $348,322.08 | -23.3% | |
| May 26, 2020 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 10,500 | $131.31 | $1,378,783.00 | -12.3% | |
| May 26, 2020 | EBS Emergent Biosolutions Inc. | Hauer Jerome M | Director | Sell | 4,385 | $85.15 | $373,373.10 | -30.1% | |
| May 26, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Lee Howard | Director | Sell | 20,000 | $18.48 | $369,628.00 | -7.2% | |
| May 22, 2020 | BMY Bristol Myers Squibb Co | Dubow Adam63 | SVP,Chiefcompliance&Ethicsoff. | Sell | 3,200 | $61.01 | $195,232.00 | -16.6% | |
| May 22, 2020 | HROW Harrow, Inc. | Opaleye Management Inc.60 | 10% Owner | Buy | 25,900 | $4.85 | $125,665.89 | +0.3% | |
| May 21, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Lee Howard | Director | Sell | 27,782 | $18.45 | $512,466.16 | -9.8% | |
| May 21, 2020 | PCRX Pacira Biosciences, Inc. | Riker Lauren Bullaro76 | Vice President, Finance | Sell | 4,000 | $44.04 | $176,140.00 | -16.0% | |
| May 20, 2020 | BUDZ Weed, Inc. | Breen Nicole M | Secretary/ Treasurer | Sell | 156,038 | $0.21 | $33,120.28 | - | |
| May 20, 2020 | SUPN Supernus Pharmaceuticals, Inc. | Patrick Gregory S | Sr.vp, Chief Financial Officer | Sell | 15,000 | $25.03 | $375,379.50 | -24.6% | |
| May 19, 2020 | AMRX Amneal Pharmaceuticals, Inc. | Kiely John | Director | Buy | 10,000 | $4.40 | $44,000.00 | New | |
| May 19, 2020 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 4,463 | $131.02 | $584,742.26 | -11.1% | |
| May 19, 2020 | DVAX Dynavax Technologies Corp | Janssen Robert71 | Senior Vice President | Sell | 15,000 | $6.33 | $94,950.00 | -7.8% | |
| May 19, 2020 | BMY Bristol Myers Squibb Co | Schmukler Louis S | EVP,Pres.,Glob.prod. &Supply | Sell | 25,000 | $62.68 | $1,567,000.00 | -48.3% | |
| May 19, 2020 | NBIX Neurocrine Biosciences Inc | Grigoriadis Dimitri E. | Chief Research Officer | Sell | 52,749 | $125.31 | $6,609,733.40 | -15.8% | |
| May 18, 2020 | COLL Collegium Pharmaceutical, Inc | Dreyer Scott54 | EVP &Chief Commercial Officer | Sell | 8,000 | $24.00 | $192,000.00 | -14.2% | |
| May 18, 2020 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 5,000 | $120.00 | $600,000.00 | -16.1% | |
| May 15, 2020 | AMRX Amneal Pharmaceuticals, Inc. | George Jeffrey P. | Director | Buy | 23,810 | $4.16 | $99,049.60 | New | |
| May 15, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Petersen Floyd F.51 | Director | Sell | 47,682 | $18.20 | $867,843.84 | -25.0% | |
| May 15, 2020 | AMPH Amphastar Pharmaceuticals, Inc. | Zasloff Michael A53 | Director | Sell | 37,782 | $18.02 | $680,656.64 | -34.8% | |
| May 14, 2020 | CVSI Cv Sciences, Inc. | Blake Paul | Director | Buy | 12,801 | $0.39 | $4,992.39 | New | |
| May 14, 2020 | ALKS Alkermes Plc. | Pops Richard F57 | Director And CEO, Alkermes Plc | Sell | 75,000 | $15.00 | $1,125,232.50 | -9.0% | |
| May 14, 2020 | RMTI Rockwell Medical, Inc. | Ellison Russell H | See Remarks | Buy | 2,000 | $2.08 | $4,160.00 | +19.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.